Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature

ClinicalTrials.gov ID: NCT01497938

Public ClinicalTrials.gov record NCT01497938. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 3:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ASPIRE (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home Study to Determine Safety and Efficacy of the LGS Feature in Sensor-augmented Pumps

Study identification

NCT ID
NCT01497938
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Medtronic MiniMed, Inc.
Industry
Enrollment
247 participants

Conditions and interventions

Interventions

  • Medtronic MMT-754 Veo Insulin pump testing Low Glucose Suspend (LGS) feature Device
  • Medtronic (NO LGS FEATURE ) using Paradigm® Revel™2.0 Pump Device

Device

Eligibility (public fields only)

Age range
16 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
May 31, 2013
Completion
May 31, 2013
Last update posted
Mar 16, 2014

2011 – 2013

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Arkansas Diabetes Clinic and Research Center Little Rock Arkansas 72205
AMCR Institute, Inc Escondido California 92026
Frank Diabetes Research Institute/ Mills-Peninsula Health Center San Mateo California 94401
University of Colorado Denver/ Barbara Davis Center for Childhood Diabetes Aurora Colorado 80045
Metabolic Research Institute West Palm Beach Florida 33401
Atlanta Diabetes Associates Atlanta Georgia 30309
Physicians Research Associates Lawrenceville Georgia 30046
Endocrine Research Solutions Roswell Georgia 30046
Rocky Mountains Diabetes and Osteoporosis Center Idaho Falls Idaho 83404
Iowa Diabetes and Endocrinology Research Center Des Moines Iowa 50314
International Diabetes Center Minneapolis Minnesota 55416
Naomie Barrie Diabetes Center New York New York 10032
Joslin Diabetes Center Syracuse New York 13210
Ohio University College of Osteopathic Medicine Athens Ohio 45701
Texas Diabetes Austin Texas 78731
Rainier Clinical Research Center Renton Washington 98057
University of Wisconsin - Madison Madison Wisconsin 53717

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01497938, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2014 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01497938 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →